A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Taiho Oncology, Inc.
Taiho Oncology, Inc.
Center for International Blood and Marrow Transplant Research
Takeda
Thomas Jefferson University
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
Cogent Biosciences, Inc.
Eli Lilly and Company
Massachusetts General Hospital
H. Lee Moffitt Cancer Center and Research Institute
Kedrion S.p.A.
Ossium Health, Inc.
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
Center for International Blood and Marrow Transplant Research
Washington University School of Medicine
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
Medical College of Wisconsin
University of Michigan Rogel Cancer Center
Nantes University Hospital
Brigham and Women's Hospital
Herlev and Gentofte Hospital
Eli Lilly and Company
M.D. Anderson Cancer Center
Stanford University
Pfizer
Fred Hutchinson Cancer Center
The First Affiliated Hospital of Guangzhou Medical University
Pfizer
Stanford University
Zhejiang University
Rigshospitalet, Denmark
University of Colorado, Denver
Fujian Medical University
Novartis
Massachusetts General Hospital
Constellation Pharmaceuticals
Centre Hospitalier Universitaire de la Réunion
Assiut University
Takeda
Dana-Farber Cancer Institute
Kelonia Therapeutics, Inc.
Zhejiang University
Rigshospitalet, Denmark
Assiut University
University of Southern California
Azienda USL Reggio Emilia - IRCCS
Assistance Publique - Hôpitaux de Paris
Azienda USL Reggio Emilia - IRCCS